Canada's IMV Inc. said its common stock was approved for listing on the Nasdaq under the IMV symbol starting June 1.
The cancer therapy developer will retain its listing on the Toronto Stock Exchange but will no longer trade on the OTCQX once it moves to Nasdaq.
